Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and ...
GREENVILLE, S.C.: Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.
ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols. By providing a chatbot interface, it ensures that users can effortlessly access crucial protocol information without the need to navigate through cumbersome documents. Key features of ProtocolCopilot™ include:
With ProtocolCopilot, clinical research professionals can focus more on critical tasks rather than getting bogged down by extensive protocol documents. This tool is especially beneficial for site staff who are often overwhelmed by the cognitive demands of managing numerous studies simultaneously.
“We are excited to bring ProtocolCopilot™ to the market, offering a cutting-edge solution that not only enhances efficiency but also supports compliance and accuracy in clinical research,” said Paul Della Maggiora, CEO of Avallano. “By leveraging the power of AI, we are addressing a significant pain point in the industry and empowering research professionals with a tool that understands their needs.”
Avallano is seeking early partners for the testing and deployment of ProtocolCopilot™. To learn more or request a demonstration, please contact Jillian Stamatis.
About Avallano
Avallano is an AI-enabled clinical trial solutions organization with a single platform to find, engage, and retain patients before, during, and after trials. We are dedicated to providing solutions that use “correct AI” to focus on the patient, decrease cognitive burden, and simplify clinical trials. Our mission is to bring clinical research back to patients using regulatory-compliant technology.
Fonte: Business Wire
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Eni's VC company invest in the Italian drone company to develop new solutions for industrial plants monitoring
Oracle recognizes Technology Reply’s ability to develop and deliver pioneering solutions through partnering with Oracle
Scheduled for October, the world's largest startup event will bring together more than 2,000 exhibitors in Dubai, UAE
Jenzabar, Inc., a leading technology innovator in higher education, today announced that Jenzabar One was named a Leader in the IDC MarketScape: North…
2024 AUDIT & BEYOND CONFERENCE — AuditBoard, the leading cloud-based platform transforming audit, risk, compliance, and ESG management, wrapped up…
TechCrunch Disrupt 2024 will feature cutting-edge technology from 24 tech startups from South Korea. The Korea Pavilion is presented by Korea Trade-Investment…
In response to the growing demand for AI skills in the workforce, University of Phoenix is excited to announce the launch of new career-focused skill…